T cell-specific deletion of the receptor for transforming growth factor-b (TGF-b) mediated by Cre recombinase expressed early in T cell development leads to early-onset lethal autoimmune disease that cannot be controlled by regulatory T cells. However, when we deleted that receptor through the use of Cre driven by a promoter that is active much later in T cell development, adult mice in which most peripheral CD4 + or CD8 + T cells lacked the receptor for TGF-b showed no signs of autoimmunity. Because of their enhanced responses to weak stimulation of the T cell antigen receptor, when transferred into lymphopenic recipients, naive TGF-b-unresponsive T cells underwent much more proliferation and differentiation into effector cells and induced lymphoproliferative disease. We propose that TGF-b signaling controls the self-reactivity of peripheral T cells but that in the absence of TGF-b signals, an added trigger such as lymphopenia is needed to drive overt autoimmune disease.
A r t i c l e s
Transforming growth factor-β (TGF-β) is a pleiotropic cytokine that regulates diverse biological processes during fetal development and in adults by binding to the type I (TGF-βRI) and type II (TGF-βRII) receptors for TGF-β found on the surface of most cells [1] [2] [3] . After binding TGF-β, TGF-βRI phosphorylates the signal transducers Smad2 and Smad3 to induce the formation of a complex with Smad4 and translocation of the complex to the nucleus. In addition, several Smad-independent pathways, such as activation of the kinases p38 and Jnk dependent on the ubiquitin ligase TRAF6 and kinase TAK1, are induced by TGF-β signaling 4, 5 . During tumorigenesis, signaling via TGF-β may initially suppress tumor growth through the regulation of cell-cycle progression, differentiation and apoptosis. However, paradoxically, at later stages, it promotes tumors both by enhancing metastasis and by its immunosuppressive effect on antitumor immunity 2, 6, 7 . In line with the antiproliferative and immunosuppressive functions of TGF-β1, mice deficient in TGF-β1 die before or shortly after birth, with an autoimmune phenotype that includes massive expansion of the T cell population and organ infiltration 8, 9 . Depleting TGF-β1-deficient mice of T cells alleviates the disease [10] [11] [12] [13] , but because TGF-β has regulatory effects on many cell types, whether or not it has a direct effect on T cells in preventing the autoimmune phenotype has remained unclear. Therefore, to elucidate the role of direct signaling from TGF-β to T cells, researchers have studied mice that express a dominant-negative transgene encoding TGF-βRII expressed selectively in T cells 14, 15 or have engineered Cre recombinase-mediated deletion of loxP-flanked alleles encoding TGF-βRII specifically in the T cell lineage (Tgfbr2 f/f CD4-Cre) 16, 17 .
In both of the models of T cell-specific unresponsiveness to TGF-β noted above, mice develop autoimmune pathology. In particular, mice with CD4-Cre-mediated deletion of loxP-flanked Tgfbr2 die very rapidly (by 3-5 weeks of age) with multiorgan autoimmune lesions, similar to what is observed in mice that completely lack TGF-β 16, 17 . The severity and rapidity of disease onset in this model of T cellspecific deletion of TGF-βRII resembles that in mice that are deficient in the transcription factor Foxp3 and therefore lack regulatory T cells (T reg cells) 18 . Because signaling by TGF-β is required for the proper development, maintenance and function of T reg cells 16, 17, [19] [20] [21] , the question has arisen of to what extent the autoimmunity in Tgfbr2 f/f CD4-Cre mice is due to the failure of T reg cell function and how much is due to the intrinsic inability of TGF-β-unresponsive T cells to control their self-reactivity. The latter has been shown to be relevant because neither transfer of wild-type T reg cells into the mice with conditional deletion of TGF-βRII nor the generation of mixed-bone marrow chimeras reconstituted with bone marrow from wild-type mice and mice with conditional deletion of TGF-βRII prevents the onset of autoimmunity in the Tgfbr2 f/f CD4-Cre model 16, 17 .
During their differentiation, T cells are positively selected for lowaffinity reactivity to self antigens expressed in the thymus. T cells with too high of an affinity for self are deleted by negative selection, yet the population of peripheral CD4 + or CD8 + T cells retains an affinity for self antigen 22 . For a fraction of T cells, their self-reactivity is of sufficient potency to cause clinical signs of autoimmunity under various 'provocations' . Tonic 'tickling' of the T cell antigen receptor (TCR) by engagement with self ligands in the periphery is needed to maintain the viability of naive T cells. Under normal, lymphoreplete conditions, this weak TCR signaling does not drive T cell division or overt activation. However, in lymphopenic conditions, combined signals from the TCR and the homeostatic γ-chain cytokines interleukin 7 (IL-7) and IL-15 drive the slow homeostatic proliferation of most T cells 23 . When transferred into lymphopenic hosts with longterm immunodeficiency, such as mice deficient in recombinationactivating gene 1 (Rag1 −/− mice), a fraction of T cells undergo rapid IL-7-and IL-15-independent proliferation that is dependent on signals from commensal microbiota 24, 25 . Finally, lymphopenia has been associated with autoimmunity [26] [27] [28] .
We have studied a different model of T cell-specific conditional deletion of TGF-βRII by Cre driven by the distal promoter of the gene encoding the kinase Lck (dLck-Cre) in which deletion occurred slowly in the periphery. This was in contrast to the CD4-Cre-mediated deletion, in which all thymus emigrants lacked the receptor. Unexpectedly, in the dLck deletion model, we observed that adult mice in which most peripheral CD4 + T cells and CD8 + T cells lacked the TGF-β receptor did not develop signs of autoimmunity. We hypothesize that CD4-Cre-mediated early and efficient deletion of TGF-βRII coupled with neonatal lymphopenia were together responsible for the rapid, severe autoimmunity. In many in vivo and in vitro experiments, we found that TGF-β-unresponsive T cells differed from control, TGF-β-responsive T cells in their enhanced responses to weak TCR stimuli. We propose that constitutive signaling by TGF-β controls the selfreactivity of peripheral T cells, but that even in the absence of TGF-β responsiveness, an added trigger, such as lymphopenia, is needed to drive overt autoimmune disease.
RESULTS

Deletion of TGF-bRII via dLck-Cre in adult mice
To study the function of TGF-β signaling in mature T cells, we bred mice bearing loxP-flanked alleles encoding TGF-βRII (Tgfbr2 f/f ) with mice expressing Cre recombinase under the control of the distal Lck promoter that is only turned on after positive selection of thymocytes (dLck-Cre) 29, 30 to generate Tgfbr2 f/f dLck-Cre mice (called 'TGF-βRII-deficient mice' here) and Tgfbr2 f/+ dLck-Cre and Tgfbr2 +/+ dLck-Cre mice (collectively called 'control mice' here). In adult mice, dLck-Cre-mediated deletion of TGF-βRII on peripheral CD4 + T cells and CD8 + T cells was almost complete, as shown by their surface staining of TGF-βRII, which was indistinguishable from that of cells stained with isotype-matched control antibody (Fig. 1a) . The expression of CD103 (integrin α E β 7 ) on mature CD8 + T cells has been linked to TGF-β signaling 31 , and the lack of CD103 expression on TGF-βRII-deficient CD8 + T cells (Fig. 1a) supported the conclusion that dLck-Cre efficiently mediated the deletion of TGF-βRII on mature T cells in adult mice. CD4 + T cells and CD8 + T cells in adult TGF-βRII-deficient mice were skewed toward an effector or memory phenotype, defined by expression of CD44 and CD62L (Fig. 1b) , and this correlated with higher expression of the T helper type 1 cell-associated transcription factor T-bet (Fig. 1c) . We did not observe more T-bet in T cells with a naive phenotype (CD44 lo CD62L + ) in TGF-βRII-deficient mice (Fig. 1c) . However, we observed no lymphoproliferation or signs of autoimmune diseases in TGF-βRII-deficient mice, all of which remained healthy for up to a year. In contrast, Tgfbr2 f/f CD4-Cre mice bred and maintained in the same animal facility showed considerable lymphocytic infiltration in many organs early in life (Supplementary Fig. 1 ) and were moribund by 3-5 weeks of age, as has been reported before for CD4-Cre-mediated deletion of TGF-βRII 16, 17 . In contrast to the abundant lymphocytic infiltrates observed in 3-weekold Tgfbr2 f/f CD4-Cre mice, the histology of Tgfbr2 f/f dLck-Cre mice was normal even at 18 weeks of age (Supplementary Fig. 1) . Therefore, the inability of most peripheral T cells to respond to TGF-β did not lead to autoimmune disease in adult mice.
Inefficient deletion of TGF-bRII in neonatal mice
How could the strikingly different outcomes of the use of dLckCre versus CD4-Cre to delete TGF-βRII on T cells be explained? There are many factors that may have contributed to the difference. Given that lymphopenia has been linked to autoimmunity [26] [27] [28] , we turned our attention to the importance of lymphopenia during the neonatal period to explain the different phenotypes of these two models of T cell-specific unresponsiveness to TGF-β. At neonatal day 4, the expression of TGF-βRII on peripheral T cells was indistinguishable in TGF-βRII-deficient (Tgfbr2 f/f dLck-Cre) mice and their TGF-βRII-sufficient (Tgfbr2 f/+ dLck-Cre and Tgfbr2 f/+ ) littermates (Supplementary Fig. 2a ). Even at 21 d of age, in TGF-βRII-deficient mice, a considerable proportion of thymic and peripheral T cells retained their expression of TGF-βRII. In contrast, all T cells that emerged from the thymus of mice expressing CD4-Cre had deletion of TGF-βRII (Supplementary Fig. 2b) . Therefore, during the neonatal lymphopenic period in newborn mice, CD4-Cre efficiently deleted Tgfbr2 and led to autoimmunity, whereas dLck-Cre was effective later and mediated efficient deletion only in adult mice, with no resulting disease.
TGF-b inhibits lymphopenia-induced proliferation
To investigate whether lymphopenia could contribute to the autoimmune phenotype of mice with TGF-β-unresponsive T cells, we turned to mixed-cell transfer. We mixed together equal numbers of allelically marked naive T cells isolated from control (Tgfbr2 f/+ dLckCre) mice and TGF-βRII-deficient mice and transferred the cells into Rag1 −/− recipients (Fig. 2a,b) . We labeled the cells with the cytosolic dye CFSE before transfer to monitor their proliferation. A fraction of the control T cells completely diluted their CFSE within a week (Fig. 2c) , which corresponded to the fast proliferation dependent on complexes of self and/or environmental peptide and major histocompatibility complex reported in such recipient mice 24, 25 . In addition, a subset of control T cells underwent a few rounds of slow IL-7-or IL-15-dependent homeostatic proliferation (Fig. 2c) . In contrast to the activity of the control T cells, slow homeostatic proliferation was almost undetectable in the transferred TGF-βRII-deficient T cells, most of which underwent fast proliferation at both day 5.5 and day 7 (Fig. 2c) . The enhanced proliferation of the TGF-βRII-deficient T cells resulted in a yield of CD4 + T cells and CD8 + T cells that was three-to fivefold greater (day 5.5) and fivefold greater (day 7) than To study the long-term effects of the enhanced proliferation of TGF-βRII-deficient T cells, we isolated naive T cells from control and TGF-βRII-deficient mice, and transferred the cells separately into Rag1 −/− recipients. Starting at 4 weeks after transfer, Rag1 −/− mice that had received TGF-βRII-deficient T cells showed more weight loss than did the control group (Fig. 3a) . In line with that, both CD4 + and CD8 + TGF-βRII-deficient T cells accumulated much more than control cells did in all organs examined (five-to seven-fold more accumulation of TGF-βRII-deficient CD4 + T cells and nine-to seventeen-fold more accumulation of TGF-βRII-deficient CD8 + T cells; Fig. 3b ). The considerably greater lymphocytic infiltration in the liver and small intestines of Rag1 −/− mice that received TGF-βRII-deficient T cells than in those of mice that received control cells further confirmed that finding (Supplementary Fig. 3 ). Therefore, we concluded that signaling from TGF-β directly to naive T cells inhibited their rapid proliferation, the acquisition of effector functions and autoimmunity in Rag1 −/− recipient mice.
Microbiota-independent rapid proliferation
Because the rapid proliferation of T cells transferred into chronically immunodeficient recipients is much lower in germ-free mice, commensal flora are considered a prerequisite for this rapid T cell proliferation 24, 32 . Both inflammatory signals and antigens from commensal bacteria are required for autoimmunity in these lymphopenic settings. To delineate the underlying mechanisms of the enhanced rapid proliferation of TGF-β-unresponsive T cells, we did experiments similar to those reported above (Fig. 2) , except that we pretreated the recipient Rag1 −/− mice with antibiotics for 7 d before T cell transfer to diminish the commensal bacteria and basal inflammation (Supplementary Fig. 4a ). As expected, the rapid proliferation of T cells from control mice was much lower in recipients treated with antibiotics ( Fig. 2c and Supplementary Fig. 4b) . However, the rapid proliferation of TGF-βRII-deficient T cells was similar with or without antibiotic treatment of the Rag1 −/− recipients. As a result, the population expansion of TGF-βRII-deficient T cells relative to that of control T cells was greater in the antibiotic-treated hosts ( Fig. 2d  and Supplementary Fig. 4c) .
In additional experiments, we transferred naive T cells from control and TGF-βRII-deficient mice together into sublethally irradiated wild-type hosts (Fig. 4a) . In contrast to hosts with chronic lymphopenia, these hosts with acute lymphopenia did not support the rapid proliferation of naive T cells from control mice 24, 25 (Fig. 4b) . However, a substantial proportion of naive T cells derived from TGF-βRII-deficient mice underwent rapid proliferation in sublethally irradiated wild-type C57BL/6 (B6) mice (Fig. 4b) . The enhanced proliferation of TGF-βRII-deficient T cells resulted in a much greater yield of both CD4 + T cells and CD8 + T cells than that of control T cells in all organs examined (Fig. 4c) . Furthermore, TGF-βRII-deficient T cells had a greatly enhanced effector function and phenotype, including expression of IFN-γ, granzyme B and KLRG1 protein (Fig. 4d) , which was consistent with the greater frequency TGF-βRII-deficient T cells that expressed T-bet and Eomes (Fig. 4d) . We obtained similar results when we transferred purified naive OT-I T cells (which have transgenic expression of a TCR restricted to major histocompatibility complex class I) into Rag1 −/− mice or sublethally irradiated wild-type B6 mice (Supplementary Fig. 5 ). Consistent with published work 24 , wild-type OT-I T cells did not undergo fast proliferation in either the Rag1 −/− or sublethally irradiated B6 recipients. In contrast, a considerable proportion of TGF-βRII-deficient OT-I T cells completely diluted their CFSE staining ( Supplementary Fig. 5b,c) . These data suggested that in contrast to control T cells, TGF-βRII-deficient T cells may not have required stimulation from bacterial flora or foreign antigens to undergo rapid proliferation in immunodeficient hosts. That interpretation was supported by our finding that the proliferation of TGF-βRII-deficient OT-I T cells in a lymphoreplete host in response to Listeria monocytogenes or vesicular stomatitis virus expressing chicken ovalbumin was the same as that of control OT-I T cells transferred together with the TGF-βRII-deficient OT-I T cells (data not shown). We concluded that weak TCR stimuli from self peptides may have been the driving force for the rapid proliferation of TGF-β-unresponsive T cells in the lymphopenic environment.
TGF-b inhibits responses to weak TCR stimuli in vitro
To study the effect of TGF-β signaling on T cell proliferation in response to weak TCR stimuli, we stimulated OT-I CD8 + T cells with a panel of altered peptide ligands derived from the cognate SIINFEKL peptide of ovalbumin that have been characterized for their potency 33 . 
We isolated naive CD8 + T cells from control and TGF-βRII-deficient OT-I mice, then mixed the cells together and labeled them with CFSE (Fig. 5a) . We depleted splenocyte populations of T cells and natural killer (NK) cells, then pulsed the splenocytes with the various altered peptide ligands and used these cells as antigen-presenting cells (APCs) in the presence of added TGF-β1. We added IL-2 1 d later and monitored the cultures for another 4 d. We found that high-affinity peptide ligands such as N4 (the cognate ligand) and the variant Y3 induced only slightly enhanced population expansion of TGF-βRII-deficient OT-I cells during the 5-day culture (less than threefold; Fig. 5b) . Notably, as the peptide potency decreased, the population expansion of TGF-βRII-deficient OT-I cells increased considerably, such that by day 4, TGF-βRII-deficient OT-I T cells outnumbered control OT-I T cells by 100-fold in cultures stimulated with T4, the ligand of lowest affinity (Fig. 5b,c) . We detected no population expansion in the absence of peptide (Fig. 5b,c) . The regulatory activity of TGF-β is modulated by the presence of inflammatory cytokines in other cell types 1 . Indeed, treatment with the proinflammatory cytokines IFN-α and IL-12 resulted in a much lower proliferative advantage of TGF-βRII-deficient OT-I cells over control OT-I cells, whereas other proinflammatory cytokines, such as IFN-γ, IL-6, TNF, IL-1β and IL-18, had a minimal effect or no effect (Fig. 5c and data not shown) . To rule out the possibility that the observed effects were unrelated to the TGF-β unresponsiveness of the TGF-βRII-deficient T cells, we added neutralizing antibody to TGF-β to the control cultures stimulated with T4; this resulted in the proliferation of control OT-I cells to the same extent as that of TGF-βRII-deficient cells (Fig. 5c) . Therefore, TGF-β signaling considerably inhibited the proliferative response of CD8 + T cells to weak TCR stimuli, whereas it had minimal effects on strong stimulation via the TCR.
To address the possibility that TGF-βRII-deficient T cells with a naive phenotype were already programmed to act differently than npg control T cells acted, we sought to determine if the effect of TGF-β could be reproduced in wild-type naive cells. We purified wild-type naive OT-I cells, labeled them with CFSE and mixed them with peptide-pulsed APCs at a ratio of 1:1 in the presence of TGF-β1 or neutralizing antibody to TGF-β. We added IL-2 the next day and monitored the cultures for another 4 d. After strong stimulation of the TCR (N4 at a concentration of 5 ng/ml), the presence or absence of TGF-β signaling had a minimal effect on the proliferation of wildtype OT-I cells (Fig. 6) . However, as the intensity of the TCR stimulation decreased, the inhibitory effects of TGF-β on wild-type OT-I cells increased considerably. For example, after stimulation with N4 at a concentration of 0.2 ng/ml (strong agonist peptide) or T4 at a concentration of 5 ng/ml (weak agonist peptide), inhibition of TGF-β signaling resulted in a sevenfold greater yield of OT-I cells during the 5-day culture (Fig. 6a) . For stimulation with T4 at a concentration of 1 ng/ml, the yield of OT-I cells was 55-fold greater after inhibition of TGF-β signaling. Thus, we found that in the presence of neutralizing antibody to TGF-β, wild-type OT-I T cells acted like TGF-βRII-deficient cells (Figs. 5 and 6) . We concluded that TGF-β signaling specifically inhibited the response to weak TCR stimulation while largely sparing the response to strong TCR stimulation.
Another possible explanation for the greater proliferation of TGF-βRII-deficient T cells in a lymphopenic environment was that TGF-βRII-deficient T cells had an enhanced response to common γ-chain cytokines, such as IL-7, IL-15 or IL-2. However, IL-2, IL-7 or IL-15 alone did not induce the proliferation of TGF-βRII-deficient OT-I T cells in vitro ( Fig. 5 and Supplementary Fig. 6 ). Furthermore, when we used sublethally irradiated Il15 −/− mice as recipients, we obtained results similar to those obtained with sublethally irradiated wild-type hosts (Fig. 4) , and in a lymphoreplete environment, TGF-βRII-deficient T cells did not respond better than wild-type cells to complexes of superagonist IL-2 and antibody to IL-2 (data not shown). Therefore, weak stimulation of the TCR was needed to induce hyperproliferative responses by TGF-βRII-deficient T cells.
CD4 + T cell help for TGF-bRII-deficient T cells
To elucidate the contributions of CD4 + T cells versus CD8 + T cells in eliciting autoimmunity in lymphopenic recipients of TGF-β-unresponsive T cells, we isolated naive CD4 + T cells and CD8 + T cells from control and TGF-βRII-deficient mice and transferred those cells separately into Rag1 −/− recipients (Fig. 7a) . There were tenfold (Fig. 7b) . In line with that, TGF-βRII-deficient CD4 + T cells rapidly induced weight loss in Rag1 −/− recipients, whereas TGF-βRII-deficient CD8 + T cells did not (Fig. 7c,d ). However, even CD4 + T cells from control mice promoted the population expansion of TGF-βRII-deficient CD8 + T cells in Rag1 −/− recipients ( Supplementary Fig. 7 ), and as a consequence, the transfer of control CD4 + T cells together with TGF-βRII-deficient CD8 + T cells precipitated the development of autoimmunity (Fig. 7d) . In summary, TGF-βRII-deficient CD4 + T cells alone and TGF-βRII-deficient CD8 + T cells with help from CD4 + T cells induced autoimmunity under lymphopenic conditions.
DISCUSSION
We have shown here that CD4 + T cells and CD8 + T cells that were unresponsive to TGF-β signals because they lacked TGF-βRII remained quiescent in the lymphoid periphery of conventionally housed, unimmunized mice. Thus, adult mice in which most peripheral T cells lacked TGF-βRII nonetheless seemed healthy, showing no signs of lymphoproliferation, weight loss or autoimmune disease for the duration of the analysis (18 weeks). That result, obtained by the T cell-specific deletion of Tgfbr2 by Cre expressed under the control of the distal Lck promoter was unexpected because it differed sharply from the outcome obtained by deletion of Tgfbr2 by Cre driven by the Cd4 promoter.
Other studies have reported 16, 17 , and we have confirmed here, that such Tgfbr2 f/f CD4-Cre mice show signs of disease shortly after birth and die by ~3-5 weeks of age with massive lymphoproliferation and multiorgan lymphocytic infiltrates. We sought to explain the strikingly different outcomes of using dLck-Cre versus CD4-Cre to delete Tgfbr2. There are many differences between the two Cre deletion models. For example, CD4-Cre is turned on at the early stage of thymopoiesis during which the transition from CD4 − CD8 − (double negative) to CD4 + CD8 + (double positive) occurs. As a result, the development of NK T cells (NKT cells) is abrogated 34 and essentially all developing T cells, including CD4 + T reg cells, lack TGF-βRII. In addition, the absence of TGF-βRII on thymocytes during the transition from CD4 + CD8 + (double positive) to CD4 + CD8 − or CD4 − CD8 + (single positive) may result in the selection of an altered TCR repertoire 35 .
In contrast, in Tgfbr2 f/f dLck-Cre mice, Cre-mediated deletion starts at the single-positive stage and continues in peripheral T cells. In this model, the development of NKT cells was normal and most peripheral T reg cells retained TGF-βRII expression (data not shown).
As for the possibility that it is the difference in the TGF-β responsiveness of T reg cells in the two models that explains the different outcomes, it is notable that other studies have reported that the injection of wild-type T reg cells into neonatal Tgfbr2 f/f CD4-Cre mice does not prevent disease, and mixed-bone marrow chimeras reconstituted with a 50:50 mixture of wild-type and Tgfbr2 f/f CD4-Cre stem cells also succumb to autoimmunity 16, 17 . Thus, it seems that wild-type T reg cells cannot prevent autoimmunity in the CD4-Cre model. Furthermore, the different responses to T reg cells cannot explain all the phenomena we observed. For example, when we transferred purified OT-I T cells into Rag1 −/− mice, there were no T reg cells present in the transferred population or in the recipients. In addition, we used purified naive OT-I T cells in our in vitro experiments, and T reg cells were not present in the culture. However, in these settings, we observed distinct differences between TGF-βRII-deficient T cells and control T cells. These data suggest that intrinsic defects other than responsiveness to T reg cells contribute to the notable phenotype of TGF-βRII-deficient T cells. Given that lymphopenia has been linked to autoimmunity [26] [27] [28] , we focused on the importance of the neonatal lymphopenic period to explain the different phenotypes of the two models of T cell-specific deletion of TGF-βRII. This was sparked by our observation that deletion of TGF-βRII was rather inefficient in the periphery and thymus of newborn and young Tgfbr2 f/f dLck-Cre mice. In contrast, all T cells that emerged from the thymus in mice expressing CD4-Cre had deleted TGF-βRII, and this included the cells that emerged during the neonatal period. Although our study has not ruled out the possibility of a contribution from other sources (such as differences in T reg cells, the presence or absence of NKT cells, or an altered TCR repertoire) for the different phenotypes of the two models, our data have shown that naive CD4 + T cells and CD8 + T cells were regulated by TGF-β signals in a lymphopenic environment. In particular, we have shown that after transfer, TGF-β-unresponsive T cells with a naive phenotype showed greater proliferation and acquisition of effector phenotype and more rapid disease induction in lymphopenic recipients than did TGF-β-responsive T cells.
Because the proliferation of naive T cells in a lymphopenic environment is partly dependent on the weak TCR stimulation derived from ligands composed of self major histocompatibility complex molecules plus self peptides 23 , we made a model of this by comparing the responses of control and TGF-βRII-deficient CD8 + T cells to potent and weak TCR stimuli in vitro. In mixed cultures of control and TGF-βRII-deficient T cells, we again observed the considerable proliferative advantage of the TGF-βRII-deficient T cells in response to weak stimulation of the TCR. Published work has shown that the weakest ligand used, T4, is about 1.4% as potent as the cognate SIINFEKL peptide in activating OT-I cells 33 and is reported to be close to the 'threshold' affinity for thymocyte positive selection versus negative selection 36 . Notably, neither differences in TCR repertoire nor npg the action of T reg cells can explain that in vitro result obtained with purified OT-I CD8 + T cells as responder cells. To rule out the possibility that defects in TGF-βRII-deficient T cells other than acute unresponsiveness to TGF-β were related to the phenotype, we cultured wild-type OT-I cells with TGF-β or in the presence of blocking antibody to TGF-β. Indeed, in the absence of TGF-β signaling, wildtype OT-I cells acted like TGF-βRII-deficient cells.
Together our results allow us to hypothesize that under noninflammatory conditions, but with enhanced exposure to self antigen, as in a lymphopenic environment, direct signaling from TGF-β to T cells is necessary for the control of T cell activation and proliferation. Our results and those of other studies have confirmed the dominant and persistent role of TGF-β in maintaining T cell homeostasis. The dampening effect on T cell activation and resultant autoimmunity is especially important when other factors, such as enhanced exposure to self antigen and greater access to homeostatic cytokines, affect peripheral T cells.
METHODS
Methods and any associated references are available in the online version of the paper.
